American Heart Journal
Volume 144, Issue 3 , Pages 530-537 , September 2002

Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy

Received 5 September 2001 ,Accepted 12 March 2002.

References 

  1. Glasser SP. Hypertension, hypertrophy, hormones, and the heart. Am Heart J. 1998;135:S16–S20
  2. Weber KT, Brilla CG, Cleland JG, et al.  Cardioreparation and the concept of modulating cardiovascular structure and function. Blood Press. 1993;2:6–21
  3. Rosendorff C. The renin-angiotensin system and vascular hypertrophy. J Am Coll Cardiol. 1996;28:803–812
  4. Pierdomenico SD, Lapenna D, Guglielmi MD, et al.  Vascular changes in hypertensive patients with different left ventricular geometry. J Hypertens. 1995;13:1701–1706
  5. Roman MJ, Saba PS, Pini R, et al.  Parallel cardiac and vascular adaptation in hypertension. Circulation. 1992;86:1909–1918
  6. Saba PS, Roman MJ, Pini R, et al.  Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. J Am Coll Cardiol. 1993;22:1873–1880
  7. Shimamoto H, Shimamoto Y. Lisinopril reverses left ventricular hypertrophy through improved aortic compliance. Hypertension. 1996;28:457–463
  8. Rizzoni D, Castellano M, Porteri E, et al.  Effects of low and high doses of fosinopril on the structure and function of resistance arteries. Hypertension. 1995;26:118–123
  9. Korner PI, Jennings GL. Assessment of prevalence of left ventricular hypertrophy in hypertension. J Hypertens. 1998;16:715–723
  10. Olsen MH, Fossum E, Hjerkinn E, et al.  Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE substudy. J Hypertens. 2000;18:75–81
  11. Dahlof B, Devereux RB, Julius S, et al.  Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Hypertension. 1998;32:989–997
  12. In: WHO Technical Reports Series 727. 1985;p. 9
  13. Palmieri V, Dahlof B, DeQuattro V, et al.  Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. J Am Coll Cardiol. 1999;34:1625–1632
  14. Howard G, Sharrett AR, Heiss G, et al.  Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke. 1993;24:1297–1304
  15. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:347–504
  16. Utriainen T, Malmstrom R, Makimattila S, et al.  Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia. 1995;38:555–564
  17. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19–26
  18. Thybo NK, Mulvany MJ, Jastrup B, et al.  Some pharmacological and elastic characteristics of isolated subcutaneous small arteries from patients with essential hypertension. J Hypertens. 1996;14:993–998
  19. Imai Y, Sasaki S, Minami N, et al.  The accuracy and performance of the A&D TM 2421, a new ambulatory blood pressure monitoring device based on the cuff-oscillometric method and the Korotkoff sound technique. Am J Hypertens. 1992;5:719–726
  20. Conway J, Coats A. Value of ambulatory blood pressure monitoring in clinical pharmacology. J Hypertens. 1989;7(Suppl):S29–S32
  21. Andersen L, Dinesen B, Jorgensen PN, et al.  Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem. 1993;39:578–582
  22. Appel E, Bayer P, Hajdu P, et al.  Determination of plasma catecholamines by means of radioenzymatic labelling and high pressure liquid chromatographic separation. Naunyn Schmiedebergs Arch Pharmacol. 1981;315:233–239
  23. Poulsen K, Jorgensen J. An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody. J Clin Endocrinol Metab. 1974;39:816–825
  24. Millar JA, Leckie BJ, Morton JJ, et al.  A microassay for active and total renin concentration in human plasma based on antibody trapping. Clin Chim Acta. 1980;101:5–15
  25. Kappelgaard AM, Nielsen MD, Giese J. Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clin Chim Acta. 1976;67:299–306
  26. Muscholl MW, Schunkert H, Muders F, et al.  Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension. Am Heart J. 1998;135:58–66
  27. Cooper A, Heagerty AM. Blood pressure parameters as determinants of small artery structure in human essential hypertension. Clin Sci Colch. 1997;92:551–557
  28. Dzau VJ, Gibbons GH. Endothelium and growth factors in vascular remodeling of hypertension. Hypertension. 1991;18(Suppl):III115–III121
  29. Lever AF. Slow developing pressor effect of angiotensin II and vascular structure. J Hypertens. 1993;11(Suppl):S27–S28
  30. Schiffrin EL, Deng LY, Larochelle P. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension. 1994;23:83–91
  31. Gibbons GH. Mechanisms of vascular remodeling in hypertension: role of autocrine-paracrine vasoactive factors. Curr Opin Nephrol Hypertens. 1995;4:189–196
  32. Head RJ. Hypernoradrenergic innervation and vascular smooth muscle hyperplastic change. Blood Vessels. 1991;28:173–178
  33. Baumbach GL, Heistad DD, Siems JE. Effect of sympathetic nerves on composition and distensibility of cerebral arterioles in rats. J Physiol. 1989;416:123–140
  34. Olsen MH, Andersen UB, Wachtell K, et al.  A possible link between endothelial dysfunction and insulin resistance in hypertension. A LIFE substudy. Blood Press. 2000;9:132–139
  35. Cunha RS, Benetos A, Laurent S, et al.  Distension capacity of the carotid artery and ambulatory blood pressure monitoring. Effects of age and hypertension. Am J Hypertens. 1995;8:343–352
  36. Intengan HD, Deng LY, Li JS, et al.  Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension. 1999;33:569–574
  37. Himeno H, Crawford DC, Hosoi M, et al.  Angiotensin II alters aortic fibronectin independently of hypertension. Hypertension. 1994;23:823–826
  38. Albaladejo P, Bouaziz H, Duriez M, et al.  Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension. 1994;23:74–82
  39. Jones EC, Devereux RB, O'Grady MJ, et al.  Relation of hemodynamic volume load to arterial and cardiac size. J Am Coll Cardiol. 1997;29:1303–1310
  40. Roman MJ, Ganau A, Saba PS, et al.  Impact of arterial stiffening on left ventricular structure. Hypertension. 2000;36:489–494
  41. Westerhof N, Sipkema P, Bos GC, et al.  Forward and backward waves in the arterial system. Cardiovasc Res. 1972;6:648–656
  42. O'Rourke MF, Yaginuma T, Avolio AP. Physiological and pathophysiological implications of ventricular/vascular coupling. Ann Biomed Eng. 1984;12:119–134

☆ Supported in part by grants from The Danish Medical Association Research Fund, Copenhagen, The Becket-Foundation, Copenhagen, Denmark, and Merck and Co, Inc, West Point, Pa, as part of the LIFE-ICARUS substudy.

☆☆ Reprint requests: Michael Hecht Olsen, MD, Department of Clinical Physiology and Nuclear Medicine, Glostrup Hospital, University of Copenhagen, DK-2600 Glostrup, Denmark.

★ E-mail: mho@dadlnet.dk

PII: S0002-8703(02)00119-9

doi: 10.1067/mhj.2002.124863

American Heart Journal
Volume 144, Issue 3 , Pages 530-537 , September 2002

Article Tools

* Image Usage & Resolution